Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

NCT04725448 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Sarcomatoid Carcinoma
Non-small Cell Lung Cancer
Lung Diseases
Thoracic Neoplasms

Interventions

DRUG: Toripalimab
DRUG: Bevacizumab
DRUG: Nab-paclitaxel
DRUG: Carboplatin

Sponsor

Sichuan Cancer Hospital and Research Institute